Crossmark

Transfer of FRozen Encapsulated multi-donor Stool filtrate for active ulcerative Colitis (FRESCO): study protocol for a prospective, multicenter, double-blind, randomized, controlled trial

Crossref DOI link: https://doi.org/10.1186/s13063-022-06095-1

Published Online: 2022-02-22

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Stallmach, Andreas

Grunert, Philip

Stallhofer, Johannes

Löffler, Bettina

Baier, Michael

Rödel, Jürgen

Kiehntopf, Michael

Neugebauer, Sophie

Pieper, Dietmar H.

Junca, Howard

Tannapfel, Andrea

Merkel, Ute

Schumacher, Ulrike

Breternitz-Gruhne, Maria

Heller, Tabitha

Schauer, Anja

Hartmann, Michael

Steube, Arndt
Funding

Funding for this research was provided by:

Bundesministerium für Bildung und Forschung (01KG1814)

Universitätsklinikum Jena
License Information

Text and Data Mining valid from 2022-02-22

Version of Record valid from 2022-02-22
More Information

Article History

Received: 22 October 2021

Accepted: 7 February 2022

First Online: 22 February 2022

Declarations

:

: Ethical approval of the ethics committee of the Friedrich-Schiller-University Jena has been obtained. The committee’s reference number is 2021-2260-AMG-ff. Ethical approval documents of all ethics committees of all participating trial centers will be obtained. Written, informed consent to participate will be obtained from all participants before starting of screening procedures.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below